Citations

Showing 10 of 108104 citations.

Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B
Kashyap, Manoj Kumar , Spaanderman, Ide , Villa, Reymundo, Clair, James J. La , Castro, Januario E. , Castro, Januario E , Kumar, Deepak , Yu, Zhe , Kipps, Thomas J. , Burkart, Michael D.

Mayo Clinic

Aging | March 1, 2022 | Volume: 14 | Issue: 5 | Pages: 2081-2100

10.18632/aging.203924 | PMID 35230971 Get It

Incidentalomas Are Associated With an Increase in Liver Transplantation in Patients With Cirrhosis: A Single-Center Retrospective Study
Cortés, Pedro , Ghoz, Hassan , Malviya, Balkishan, Palmer, William C. , Cortés, Pedro , Stancampiano, Fernando F. , Omer, Mohamed , Bowman, Andrew W.

Mayo Clinic

No container title available | March 1, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1342298/v1 Get It

Abstract Background: Incidentalomas, defined as incidental findings on imaging, are a growing concern. Our aim was to determine the impact and outcomes of extrahepatic incidentalomas on liver transplantation.Methods: Patients at a large liver transplant center, who had an initial MRI for hepatocellular carcinoma screening between January 2004 and March 2020 were identified. Clinical data were collected retrospectively. Survival analysis, utilizing Kaplan Meier estimates and Cox proportional hazards regression analysis, was utilized to determine factors associated with liver transplantation. Results: 720 patients were included. NASH (24.9%), HCV (22.1%) and alcohol (20.6%) were the most common causes of cirrhosis. 79.7% of patients had an extrahepatic incidentaloma. Older age and having received a liver transplant by the end of the study were associated with an incidentaloma. MELD was not associated with the presence of an incidentaloma. On univariate Cox proportional hazards regression, male gender, history of moderate alcohol use, smoking history, MELD, and incidentalomas were predictors of liver transplantation. On multivariate analysis, only MELD and the presence of an incidentaloma were found to be significant. Discovery of an incidentaloma was associated with a 30% increase in the risk of liver transplantation. Median time to transplantation did not differ based on the presence on an incidentaloma. Patients with cirrhosis from alcohol or HCV had a significantly shorter median time to transplantation than those with NASH. Renal and pancreatic lesions comprised 91% of all incidentalomas.Conclusions: In this single-center retrospective study, extrahepatic incidentalomas were common in patients with cirrhosis. The finding of an incidentaloma was associated with a higher risk of liver transplantation despite a similar median time to transplantation if no incidentaloma was discovered.
A Scoping Review of Published Intimate Partner Violence Curricula for Medical Trainees
Ghaith, Summer , Voleti, Sandeep S. , Ginsberg, Zachary , Marks, Lisa , Files, Julia A. , Kling, Juliana M. , Marks, Lisa A., Kling, Juliana M , Marks, Lisa A

Mayo Clinic

Journal of Women's Health | March 1, 2022 | Volume: 31 | Issue: 11 | Pages: 1596-1613

10.1089/jwh.2021.0345 | PMID 35231186 Get It

Defining Optimal Management of Patients With Intermediate-risk Pulmonary Emboli
Houghton, Damon E.

Mayo Clinic

The Hematologist | March 1, 2022 | Volume: 19 | Issue: 2 | Pages: No page available

10.1182/hem.v19.2.202227 Get It

Autoimmune (Acquired) Hemophilia: Updates in Diagnosis and Therapy
Pruthi, Rajiv K. , Sridharan, Meera

Mayo Clinic

The Hematologist | March 1, 2022 | Volume: 19 | Issue: 2 | Pages: No page available

10.1182/hem.v19.2.2022214 Get It

Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic (VEXAS) syndrome: a presentation of two cases with dermatologic findings
Mohammed, Taha Osman , Aghazadeh, Nessa , Olteanu, Horatiu , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Cantwell, Hafsa M. , Aghazadeh Mohandesi, Nessa , Alavi, Afsáneh , Koster, Matthew J. , Warrington, Kenneth J.

Mayo Clinic

International Journal of Dermatology | March 1, 2022 | Volume: 62 | Issue: 5 | Pages: No page available

10.1111/ijd.16132 | PMID 35230710 Get It

Antiseptic Irrigation Solutions Used in Total Joint Arthroplasty
Christopher, Zachary K. , Deckey, David G. , Pollock, Jordan R. , Spangehl, Mark J. , Pollock, Jordan Riley , Spangehl, Mark

Mayo Clinic

JBJS Reviews | March 1, 2022 | Volume: 10 | Issue: 3 | Pages: No page available

10.2106/jbjs.rvw.21.00225 | PMID 35231016 Get It

» There are limited data that directly compare the efficacy of antiseptic irrigation solutions used for the prevention and treatment of periprosthetic joint infections in orthopaedic procedures; there is a notable lack of prospective data. » For prevention of periprosthetic joint infections, the strongest evidence supports the use of low-pressure povidone-iodine. » For the treatment of periprosthetic joint infections, delivering multiple solutions sequentially may be beneficial.
Faculty Opinions recommendation of Interactions of a Long Noncoding RNA with Domains of NF-κB and IκBα: Implications for the Inhibition of Non-Signal-Related Phosphorylation.
Maher, Jim

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 1, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.741659667.793591692 Get It

Off‐Pump Coronary Artery Bypass Grafting: Department of Veteran Affairs’ Use and Outcomes
Deo, Salil V. , Elgudin, Yakov, Shroyer, A. Laurie , Altarabsheh, Salah E. , Sharma, Vikas, Rubelowsky, Joseph, Cornwell, Lorraine, Davierwala, Piroze, Chu, Danny, Cmolik, Brian, Shroyer, Annie-Laurie W , Altarabsheh, Salah , Deo, Salil , Elgudin, Yakov, Sharma, Vikas, Rubelowsky, Joseph, Cornwell, Lorraine, Davierwala, Piroze, Chu, Danny, Cmolik, Brian

Mayo Clinic

Journal of the American Heart Association | March 1, 2022 | Volume: 11 | Issue: 6 | Pages: No page available

10.1161/jaha.121.023514 | PMID 35229663 Get It

Background Coronary artery bypass can be performed off pump (OPCAB) without cardiopulmonary bypass. However, trends over time for OPCAB versus on‐pump (ONCAB) use and long‐term outcome has not been reported, nor has their long‐term outcome been compared. Methods and Results We queried the national Veterans Affairs database (2005–2019) to identify isolated coronary artery bypass procedures. Procedures were classified as OPCAB on ONCAB using the as‐treated basis. Trend analyses were performed to evaluate longitudinal changes in the preference for OPCAB. The median follow‐up period was 6.6 (3.5–10) years. An inverse probability weighted Cox model was used to compare all‐cause mortality between OPCAB and ONCAB. From 47 685 patients, 6759 (age 64±8 years) received OPCAB (14%). OPCAB usage declined from 16% (2005–2009) to 8% (2015–2019). Patients with triple vessel disease who received OPCAB received a lower mean number of grafts (2.8±0.8 versus 3.2±0.8; P <0.01). The ONCAB 5‐, 10‐, and 15‐year survival rates were 82.9% (82.5–83.3), 60.4% (59.8–61.1), and 37.2% (36.1–38.4); correspondingly, OPCAB rates were 80.7% (79.7–81.7), 57.4% (56–58.7), and 34.1% (31.7–36.6) ( P <0.01). OPCAB was associated with increased risk‐adjusted all‐cause mortality (hazard ratio, 1.15 [1.13–1.18]; P <0.01) and myocardial infarction (incident rate ratio, 1.16 [1.05–1.28]; P <0.01). Conclusions Over 15 years, OPCAB use declined considerably in Veterans Affairs medical centers. In Veterans Affairs hospitals, late all‐cause mortality and myocardial infarction rates were higher in the OPCAB cohort.
Feasibility of Closed-Loop Insulin Delivery with a Pregnancy-Specific Zone Model Predictive Control Algorithm
Özaslan, Başak , Kudva, Yogish C. , Pinsker, Jordan E. , O’Malley, Grenye , Kaur, Ravinder Jeet , Castorino, Kristin , Levister, Camilla, Trinidad, Mari Charisse, Desjardins, Donna, Church, Mei Mei , Plesser, Mitchell, McCrady-Spitzer, Shelly , Ogyaadu, Selassie, Nelson, Kristen L., Reid, Corey, Kremers, Walter K. , Rosenn, Barak, Dassau, Eyal , Kudva, Yogish C. , Doyle, Francis J , Dassau, Eyal , Kremers, Walter K , Levy, Carol J. , Nelson, Kristen, Deshpande, Sunil , Doyle, Francis J.

Mayo Clinic

Diabetes Technology & Therapeutics | March 1, 2022 | Volume: 24 | Issue: 7 | Pages: 471-480

10.1089/dia.2021.0521 | PMID 35230138 Get It

Objective: Evaluating the feasibility of closed-loop insulin delivery with a zone model predictive control (zone-MPC) algorithm designed for pregnancy complicated by type 1 diabetes (T1D). Research Design and Methods: Pregnant women with T1D from 14 to 32 weeks gestation already using continuous glucose monitor (CGM) augmented pump therapy were enrolled in a 2-day multicenter supervised outpatient study evaluating pregnancy-specific zone-MPC based closed-loop control (CLC) with the interoperable artificial pancreas system (iAPS) running on an unlocked smartphone. Meals and activities were unrestricted. The primary outcome was the CGM percentage of time between 63 and 140 mg/dL compared with participants' 1-week run-in period. Early (2-h) postprandial glucose control was also evaluated. Results: Eleven participants completed the study (age: 30.6 ± 4.1 years; gestational age: 20.7 ± 3.5 weeks; weight: 76.5 ± 15.3 kg; hemoglobin A1c: 5.6% ± 0.5% at enrollment). No serious adverse events occurred. Compared with the 1-week run-in, there was an increased percentage of time in 63–140 mg/dL during supervised CLC (CLC: 81.5%, run-in: 64%, P = 0.007) with less time >140 mg/dL (CLC: 16.5%, run-in: 30.8%, P = 0.029) and time <63 mg/dL (CLC: 2.0%, run-in:5.2%, P = 0.039). There was also less time <54 mg/dL (CLC: 0.7%, run-in:1.6%, P = 0.030) and >180 mg/dL (CLC: 4.9%, run-in: 13.1%, P = 0.032). Overnight glucose control was comparable, except for less time >250 mg/dL (CLC: 0%, run-in:3.9%, P = 0.030) and lower glucose standard deviation (CLC: 23.8 mg/dL, run-in:42.8 mg/dL, P = 0.007) during CLC. Conclusion: In this pilot study, use of the pregnancy-specific zone-MPC was feasible in pregnant women with T1D. Although the duration of our study was short and the number of participants was small, our findings add to the limited data available on the use of CLC systems during pregnancy (NCT04492566).